effectively managing product lifecycles 

Your last 12 months working with Combination Products have been largely focused around overcoming the lack of regulatory clarity with the imminent implementation of the EU MDR Article 117, but, as that deadline approaches – what’s next? Do you have a solid roadmap in place to ensure you get your submission right, the first time?

That’s why we’re bringing back the 4th Annual Drug-Device Combination Products Forum 2021 to focus on the entire product lifecycle management process and the serious pitfalls that need addressing. From planning, design and implementation, right the way through to post-market maintenance and surveillance strategies.

Through a fully interactive program and an expert speaker faculty, key topics will focus on risk management strategies, navigating the regulatory GMP landscape, quality system requirements, using design controls to aid development, user needs and usability, digitalisation and connected devices.

Split across three days, the forum will focus on one key question: Can you successfully launch and manage a combination product?

Meet Our Expert Speakers & Facilitators

Benefits of Attending:


How to inforce best practice following the implementation of the EU MDR Article 117


Internal procedures and change management strategy that will align drug-device departments and partners


An effective combination product strategy from initial planning, design, assessment through to post-market maintenance


Discover best practice to successfully launch your combination product, for the first time

What Our Past Attendees Have Said: